Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.

MLA

Leo, Chen Huei, et al. “Relaxin Reduces Endothelium-Derived Vasoconstriction in Hypertension: Revealing New Therapeutic Insights.” British Journal of Pharmacology, vol. 177, no. 1, Jan. 2020, pp. 217–33. EBSCOhost, https://doi.org/10.1111/bph.14858.

APA

Leo, C. H., Ng, H. H., Marshall, S. A., Jelinic, M., Rupasinghe, T., Qin, C., Roessner, U., Ritchie, R. H., Tare, M., & Parry, L. J. (2020). Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights. British Journal of Pharmacology, 177(1), 217–233. https://doi.org/10.1111/bph.14858

Chicago

Leo, Chen Huei, Hooi Hooi Ng, Sarah A. Marshall, Maria Jelinic, Thusitha Rupasinghe, Chengxue Qin, Ute Roessner, Rebecca H. Ritchie, Marianne Tare, and Laura J. Parry. 2020. “Relaxin Reduces Endothelium-Derived Vasoconstriction in Hypertension: Revealing New Therapeutic Insights.” British Journal of Pharmacology 177 (1): 217–33. doi:10.1111/bph.14858.